Somatic genomic alterations in retinoblastoma beyond RB1 are rare and limited to copy number changes

Citations Over TimeTop 10% of 2016 papers

Abstract

Retinoblastoma is a rare childhood cancer initiated by RB1 mutation or MYCN amplification, while additional alterations may be required for tumor development. However, the view on single nucleotide variants is very limited. To better understand oncogenesis, we determined the genomic landscape of retinoblastoma. We performed exome sequencing of 71 retinoblastomas and matched blood DNA. Next, we determined the presence of single nucleotide variants, copy number alterations and viruses. Aside from RB1, recurrent gene mutations were very rare. Only a limited fraction of tumors showed BCOR (7/71, 10%) or CREBBP alterations (3/71, 4%). No evidence was found for the presence of viruses. Instead, specific somatic copy number alterations were more common, particularly in patients diagnosed at later age. Recurrent alterations of chromosomal arms often involved less than one copy, also in highly pure tumor samples, suggesting within-tumor heterogeneity. Our results show that retinoblastoma is among the least mutated cancers and signify the extreme sensitivity of the childhood retina for RB1 loss. We hypothesize that retinoblastomas arising later in retinal development benefit more from subclonal secondary alterations and therefore, these alterations are more selected for in these tumors. Targeted therapy based on these subclonal events might be insufficient for complete tumor control.

Related Papers

• → The landscape of chromothripsis across adult cancer types(2020)189 cited
• → The combination of whole‐exome sequencing and copy number variation sequencing enables the diagnosis of rare neurological disorders(2019)46 cited
• → Is screening for primitive neuroectodermal tumors in patients with unilateral retinoblastoma necessary?(2000)11 cited
• Germline retinoblastoma without inherited gene mutation: a case report.(2014)
• → Faculty Opinions recommendation of Detection of clinically relevant copy-number variants by exome sequencing in a large cohort of genetic disorders.(2020)